The Brazilian Pharmaceutical & Health Sector

The Brazilian Pharmaceutical & Health Sector

  • July 2015 •
  • 37 pages •
  • Report ID: 3752640 •
  • Format: PDF
The Brazilian pharmaceutical sector is estimated to have grown at an average annual rate of 14.2% between 2007 and 2015, reaching revenues of US$ 23 billion. Generics have gained considerable relevance and currently represent 26% of the market compared to merely 12% in 2007. Exports only represent about 7% of sales and the sector’s trade balance has remained negative, reaching a deficit of US$ 6.6 billion in 2015. Families’ spend with health increased 114% over the past 8 years but hospital beds per inhabitant have dropped below the minimum threshold recommended by the World Health Organization. United States and European Union remain the main players in the global pharmaceutical foreign trade.

This report analyses the subject market in Brazil, its main products and services, main players’ performance and the Brazilian pharmaceutical market in the global scenario.
Loading...

We are very sorry, but an error occurred.
Please contact support@reportbuyer.com if the problem remains.